Cancer Epigenetics: New Mechanisms, New Therapies (B4)

30. November 2017

10th to 14th February 2018, Breckenridge, CO, USA. The field of epigenetics has recently emerged as an essential component of oncology research, with altered epigenetic modifications considered to be critical hallmarks of cancers. Unlike mutations, epigenetic aberrations are reversible and as a result, epigenetic therapies hold great promise as anti-cancer […]